News 27.10.2016 Scientists at Neurimmune described results from the Phase 1b PRIME clinical trial of the monoclonal antibody aducanumab. The report, published in the journal Nature, showed that aducanumab removed amyloid plaques from the brains of patients with early-stage Alzheimer’s disease. Importantly, amyloid plaque reductions occurred in both a dose- and time-dependent manner. After...
News 27.10.2016 Molecular Partners AG (SIX: MOLN) announced that Tarek S. Hassan, MD, Professor of Ophthalmology at Oakland University William Beaumont School of Medicine and Senior Partner and Director of the Vitreoretinal Fellowship Training Program at Associated Retinal Consultants in Royal Oak, Michigan, presented the data of PALM, A Multicenter, Double Masked Phase 2 Clinical Trial...
External events 25.10.2016 Online platform for entrepreneurs, innovators and supporters (more…)
Events, Internal events
Event date: 04.02.2025
One regular event on the site is the popular Bio-Technopark After Work Networking Aperitif. On the first Tuesday of the month, scientists, laboratory technicians, entrepreneurs, and many others meet in the Momento Caffè & Lounge in order to maintain networks, exchange ideas, and make new contacts in an informal atmosphere.
The...
External events 13.09.2016 Swiss Biotech publishs national and international life sciences events on its website. (more…)